P-380: Lean-driven structured screening for early stages of type 1 diabetes in pediatric first-degree relatives
Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)
DOI: 10.1159/hrp/adaag020.438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von P Ferreiro-Mazón und 7 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Type 1 diabetes (T1D) is an autoimmune disease with a presymptomatic phase marked by pancreatic autoimmunity and progressive dysglycemia. Screening first-degree relatives enables early identification of at-risk individuals, reduces diabetic ketoacidosis at diagnosis, and facilitates monitoring. Lean-based structured programs may improve implementation in clinical practice.
Objectives
To characterize clinical, immunological, and metabolic outcomes of a structured T1D screening program in pediatric first-degree relatives and classify participants by presymptomatic stages.
Methods
Observational study conducted in a tertiary referral center within a Lean-based program. Between July 2025 and January 2026, 148 children with a first-degree relative with T1D were screened. Autoantibodies (anti-IA2, anti-insulin, anti-GAD, anti-ZnT8) were measured. In positive cases (≥1 autoantibody), demographic data, autoimmune history, fasting glucose, HbA1c, and OGTT when indicated were collected. Staging was based on autoantibody number and glycemic status.
Results
Seventeen children (11.4%) had ≥1 autoantibody. Median age was 12 years (IQR 6.5–13.5); 52.9% were male. The affected relative was a sibling (41.2%), father (41.2%), or mother (17.6%). Two patients had celiac disease. Most (88.2%) had one autoantibody; 5.9% had two and 5.9% three. Anti-GAD was most frequent (58.8%). Fasting glucose was normal in all cases (median 89 mg/dL), and median HbA1c was 5.3%. One OGTT showed 120-min glucose of 145 mg/dL. Staging classified 88.2% as at-risk, 5.9% as stage 1, and 5.9% as stage 2 T1D.
Conclusions
Lean-based structured screening enables identification of children in presymptomatic T1D stages. Detection of stage 1–2 cases support the clinical value of organized screening and its role in early detection in high-risk pediatric populations.
Zitieren
APA
Ferreiro-Mazón, P., Martín, N. I., Domínguez, Ó. M., Gil, M. C., Soto, A. B., Villar, N. G. P. D., Carcavilla, A., & Casado, I. G. (2026). P-380: Lean-driven structured screening for early stages of type 1 diabetes in pediatric first-degree relatives. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.438
Vancouver
Ferreiro-Mazón P, Martín NI, Domínguez ÓM, Gil MC, Soto AB, Villar NGPD, et al. P-380: Lean-driven structured screening for early stages of type 1 diabetes in pediatric first-degree relatives. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.438
BibTeX
@article{FerreiroMazn2026,
author = {Ferreiro-Mazón, P and Martín, N Itza and Domínguez, Ó Moreno and Gil, M Camacho and Soto, A Buño and Villar, N González Perez De and Carcavilla, A and Casado, I González},
title = {P-380: Lean-driven structured screening for early stages of type 1 diabetes in pediatric first-degree relatives},
journal = {Hormone Research in Paediatrics},
year = {2026},
volume = {99},
number = {Supplement_4},
doi = {10.1159/hrp/adaag020.438}
}
EUVIMED